Trial Information

Summary: RECURRING BLADDER PAIN OR DISCOMFORT?

FREQUENT TRIPS TO THE BATHROOM? YOU MAY HAVE INTERSTITAL CYSTITIS. A designated medical facility is taking part in a clinical research study of a currently approved oral medication for the relief of bladder pain or discomfort associated with interstitial cystitis. For more information or to find out if you may qualify, please email puaresearch@yahoo.com. Study Participants Must: have recurrent bladder pain or discomfort with urinary urgency or frequency, be willing to attend up to 9 visits to a doctors office over a period of 6 months.

Key Inclusion Criteria 1. Women or men at least 18 years of age 2. Subject must have bladder pain or discomfort with urinary urgency, not related to urinary tract infection, for at least the past 6 month 3. Female patients using Hormone Replacement Therapy (HRT) must have been using HRT for at least the previous 3 months 4. Participants average ≥10 voids per day and average ≥1 nocturnal voids 5. Patients currently taking ELMIRON® can be enrolled after a 4 week wash-out period 6. Patients must be able to understand, speak and read English

Key Exclusion Criteria 1. Pregnant or breast-feeding women 2. Any of the following conditions: Surgery in the past 4 weeks Bladder diseases other than IC Chronic pain conditions Men: chronic prostatitis, or prostate cancer Women: significant vaginitis, or female cancers 3. Any of the following medications: Intravesical therapy (DMSO) Oral meds for IC (antidepressants, antihistamines, antispasmodics, anticholinergics, etc.) Chronic narcotics as well as Darvon®, Darvocet® or Utram® Coumadin/warfarin, heparin, Plavix®/clopidogrel, tPA, or strptokinase

If you would like to learn more about participating in this study, please send an e-mail message using the form below.